The vasoprotective role of IGF-1 signaling in the cerebral microcirculation: prevention of cerebral microhemorrhages in aging.

Aging CSVD Cerebral small vessel disease Hypertension Hypertensive Insulin-like Growth Factor 1 Microbleed

Journal

GeroScience
ISSN: 2509-2723
Titre abrégé: Geroscience
Pays: Switzerland
ID NLM: 101686284

Informations de publication

Date de publication:
14 Sep 2024
Historique:
received: 02 08 2024
accepted: 05 09 2024
medline: 14 9 2024
pubmed: 14 9 2024
entrez: 13 9 2024
Statut: aheadofprint

Résumé

Aging is closely associated with various cerebrovascular pathologies that significantly impact brain function, with cerebral small vessel disease (CSVD) being a major contributor to cognitive decline in the elderly. Consequences of CSVD include cerebral microhemorrhages (CMH), which are small intracerebral bleeds resulting from the rupture of microvessels. CMHs are prevalent in aging populations, affecting approximately 50% of individuals over 80, and are linked to increased risks of vascular cognitive impairment and dementia (VCID). Hypertension is a primary risk factor for CMHs. Vascular smooth muscle cells (VSMCs) adapt to hypertension by undergoing hypertrophy and producing extracellular matrix (ECM) components, which reinforce vessel walls. Myogenic autoregulation, which involves pressure-induced constriction, helps prevent excessive pressure from damaging the vulnerable microvasculature. However, aging impairs these adaptive mechanisms, weakening vessel walls and increasing susceptibility to damage. Insulin-like Growth Factor 1 (IGF-1) is crucial for vascular health, promoting VSMC hypertrophy, ECM production, and maintaining normal myogenic protection. IGF-1 also prevents microvascular senescence, reduces reactive oxygen species (ROS) production, and regulates matrix metalloproteinase (MMP) activity, which is vital for ECM remodeling and stabilization. IGF-1 deficiency, common in aging, compromises these protective mechanisms, increasing the risk of CMHs. This review explores the vasoprotective role of IGF-1 signaling in the cerebral microcirculation and its implications for preventing hypertension-induced CMHs in aging. Understanding and addressing the decline in IGF-1 signaling with age are crucial for maintaining cerebrovascular health and preventing hypertension-related vascular injuries in the aging population.

Identifiants

pubmed: 39271571
doi: 10.1007/s11357-024-01343-5
pii: 10.1007/s11357-024-01343-5
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIA NIH HHS
ID : RF1AG072295
Pays : United States
Organisme : NIA NIH HHS
ID : R01AG055395
Pays : United States
Organisme : NIA NIH HHS
ID : R01AG068295
Pays : United States
Organisme : NIA NIH HHS
ID : R01AG070915
Pays : United States
Organisme : NINDS NIH HHS
ID : R01NS100782
Pays : United States
Organisme : NCI NIH HHS
ID : R01CA255840
Pays : United States

Informations de copyright

© 2024. The Author(s).

Références

Toth P, Tarantini S, Csiszar A, Ungvari Z. Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging. Am J Physiol Heart Circ Physiol. 2017;312:H1–20. https://doi.org/10.1152/ajpheart.00581.2016 .
doi: 10.1152/ajpheart.00581.2016 pubmed: 27793855
Ungvari Z, Toth P, Tarantini S, Prodan CI, Sorond F, Merkely B, Csiszar A. Hypertension-induced cognitive impairment: from pathophysiology to public health. Nat Rev Nephrol. 2021;17:639–54. https://doi.org/10.1038/s41581-021-00430-6 .
doi: 10.1038/s41581-021-00430-6 pubmed: 34127835 pmcid: 8202227
Csiszar A, Ungvari A, Patai R, Gulej R, Yabluchanskiy A, Benyo Z, Kovacs I, Sotonyi P, Kirkpartrick AC, Prodan CI, et al. Atherosclerotic burden and cerebral small vessel disease: exploring the link through microvascular aging and cerebral microhemorrhages. Geroscience. 2024. https://doi.org/10.1007/s11357-024-01139-7 .
doi: 10.1007/s11357-024-01139-7 pubmed: 38914916 pmcid: 11335995
Mukli P, Detwiler S, Owens CD, Csipo T, Lipecz A, Pinto CB, Tarantini S, Nyul-Toth A, Balasubramanian P, Hoffmeister JR, et al. Gait variability predicts cognitive impairment in older adults with subclinical cerebral small vessel disease. Front Aging Neurosci. 2022;14:1052451. https://doi.org/10.3389/fnagi.2022.1052451 .
doi: 10.3389/fnagi.2022.1052451 pubmed: 36466602 pmcid: 9716182
Nyul-Toth A, Patai R, Csiszar A, Ungvari A, Gulej R, Mukli P, Yabluchanskiy A, Benyo Z, Sotonyi P, Prodan CI, et al. Linking peripheral atherosclerosis to blood-brain barrier disruption: elucidating its role as a manifestation of cerebral small vessel disease in vascular cognitive impairment. Geroscience. 2024. https://doi.org/10.1007/s11357-024-01194-0 .
doi: 10.1007/s11357-024-01194-0 pubmed: 38914916 pmcid: 11335995
Blitstein MK, Tung GA. MRI of cerebral microhemorrhages. AJR Am J Roentgenol. 2007;189:720–5. https://doi.org/10.2214/AJR.07.2249 .
doi: 10.2214/AJR.07.2249 pubmed: 17715122
Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2672–713. https://doi.org/10.1161/STR.0b013e3182299496 .
doi: 10.1161/STR.0b013e3182299496 pubmed: 21778438 pmcid: 3778669
Hainsworth AH, Markus HS, Schneider JA. Cerebral small vessel disease, hypertension, and vascular contributions to cognitive impairment and dementia. Hypertension. 2024;81:75–86. https://doi.org/10.1161/HYPERTENSIONAHA.123.19943 .
doi: 10.1161/HYPERTENSIONAHA.123.19943 pubmed: 38044814
Haller S, Bartsch A, Nguyen D, Rodriguez C, Emch J, Gold G, Lovblad KO, Giannakopoulos P. Cerebral microhemorrhage and iron deposition in mild cognitive impairment: susceptibility-weighted MR imaging assessment. Radiology. 2010;257:764–73. https://doi.org/10.1148/radiol.10100612 .
doi: 10.1148/radiol.10100612 pubmed: 20923870
Haller S, Vernooij MW, Kuijer JPA, Larsson EM, Jager HR, Barkhof F. Cerebral microbleeds: imaging and clinical significance. Radiology. 2018;287:11–28. https://doi.org/10.1148/radiol.2018170803 .
doi: 10.1148/radiol.2018170803 pubmed: 29558307
Viswanathan A, Chabriat H. Cerebral microhemorrhage. Stroke. 2006;37:550–5. https://doi.org/10.1161/01.STR.0000199847.96188.12 .
doi: 10.1161/01.STR.0000199847.96188.12 pubmed: 16397165
Ungvari Z, Tarantini S, Kirkpatrick AC, Csiszar A, Prodan CI. Cerebral microhemorrhages: mechanisms, consequences, and prevention. Am J Physiol Heart Circ Physiol. 2017;312:H1128–43. https://doi.org/10.1152/ajpheart.00780.2016 .
doi: 10.1152/ajpheart.00780.2016 pubmed: 28314762 pmcid: 5495931
Barus R, Bergeron S, Auger F, Laloux C, Skrobala E, Bongiovanni A, Potey C, Bordet R, Chen Y, Gautier S. Sex differences in cognitive impairment induced by cerebral microhemorrhage. Transl Stroke Res. 2021;12:316–30. https://doi.org/10.1007/s12975-020-00820-1 .
doi: 10.1007/s12975-020-00820-1 pubmed: 32440818
Dichgans M, Leys D. Vascular cognitive impairment. Circ Res. 2017;120:573–91. https://doi.org/10.1161/CIRCRESAHA.116.308426 .
doi: 10.1161/CIRCRESAHA.116.308426 pubmed: 28154105
Csiszar A, Tarantini S, Fulop GA, Kiss T, Valcarcel-Ares MN, Galvan V, Ungvari Z, Yabluchanskiy A. Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer’s disease. Geroscience. 2017;39:359–72. https://doi.org/10.1007/s11357-017-9991-9 .
doi: 10.1007/s11357-017-9991-9 pubmed: 28853030 pmcid: 5636770
Bickel MA, Csik B, Gulej R, Ungvari A, Nyul-Toth A, Conley SM. Cell non-autonomous regulation of cerebrovascular aging processes by the somatotropic axis. Front Endocrinol (Lausanne). 2023;14:1087053. https://doi.org/10.3389/fendo.2023.1087053 .
doi: 10.3389/fendo.2023.1087053 pubmed: 36755922
Bailey-Downs LC, Mitschelen M, Sosnowska D, Toth P, Pinto JT, Ballabh P, Valcarcel-Ares MN, Farley J, Koller A, Henthorn JC, et al. Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular aging. J Gerontol A Biol Sci Med Sci. 2012;67:313–29. https://doi.org/10.1093/gerona/glr164 .
doi: 10.1093/gerona/glr164 pubmed: 22021391
Bailey-Downs LC, Sosnowska D, Toth P, Mitschelen M, Gautam T, Henthorn JC, Ballabh P, Koller A, Farley JA, Sonntag WE, et al. Growth hormone and IGF-1 deficiency exacerbate high-fat diet-induced endothelial impairment in obese lewis dwarf rats: implications for vascular aging. J Gerontol A Biol Sci Med Sci. 2012;67:553–64. https://doi.org/10.1093/gerona/glr197 .
doi: 10.1093/gerona/glr197 pubmed: 22080499
Farias Quipildor GE, Mao K, Hu Z, Novaj A, Cui MH, Gulinello M, Branch CA, Gubbi S, Patel K, Moellering DR, et al. Central IGF-1 protects against features of cognitive and sensorimotor decline with aging in male mice. Geroscience. 2019;41:185–208. https://doi.org/10.1007/s11357-019-00065-3 .
doi: 10.1007/s11357-019-00065-3 pubmed: 31076997 pmcid: 6544744
Fulop GA, Ramirez-Perez FI, Kiss T, Tarantini S, Valcarcel Ares MN, Toth P, Yabluchanskiy A, Conley SM, Ballabh P, Martinez-Lemus LA, et al. IGF-1 deficiency promotes pathological remodeling of cerebral arteries: a potential mechanism contributing to the pathogenesis of intracerebral hemorrhages in aging. J Gerontol A Biol Sci Med Sci. 2018. https://doi.org/10.1093/gerona/gly144 .
doi: 10.1093/gerona/gly144 pmcid: 6696715
Gulej R, Csik B, Faakye J, Tarantini S, Shanmugarama S, Chandragiri SS, Mukli P, Conley S, Csiszar A, Ungvari Z, et al. Endothelial deficiency of insulin-like growth factor-1 receptor leads to blood-brain barrier disruption and accelerated endothelial senescence in mice, mimicking aspects of the brain aging phenotype. Microcirculation. 2024;31: e12840. https://doi.org/10.1111/micc.12840 .
doi: 10.1111/micc.12840 pubmed: 38082450
Kiss T, Nyul-Toth A, Gulej R, Tarantini S, Csipo T, Mukli P, Ungvari A, Balasubramanian P, Yabluchanskiy A, Benyo Z, et al. Old blood from heterochronic parabionts accelerates vascular aging in young mice: transcriptomic signature of pathologic smooth muscle remodeling. Geroscience. 2022;44:953–81. https://doi.org/10.1007/s11357-022-00519-1 .
doi: 10.1007/s11357-022-00519-1 pubmed: 35124764 pmcid: 9135944
Miller LR, Bickel MA, Vance ML, Vaden H, Nagykaldi D, Nyul-Toth A, Bullen EC, Gautam T, Tarantini S, Yabluchanskiy A, et al. Vascular smooth muscle cell-specific Igf1r deficiency exacerbates the development of hypertension-induced cerebral microhemorrhages and gait defects. Geroscience. 2024;46:3481–501. https://doi.org/10.1007/s11357-024-01090-7 .
doi: 10.1007/s11357-024-01090-7 pubmed: 38388918 pmcid: 11009188
Miller LR, Tarantini S, Nyul-Toth A, Johnston MP, Martin T, Bullen EC, Bickel MA, Sonntag WE, Yabluchanskiy A, Csiszar A, et al. Increased susceptibility to cerebral microhemorrhages is associated with imaging signs of microvascular degeneration in the retina in an insulin-like growth factor 1 deficient mouse model of accelerated aging. Front Aging Neurosci. 2022;14: 788296. https://doi.org/10.3389/fnagi.2022.788296 .
doi: 10.3389/fnagi.2022.788296 pubmed: 35356301 pmcid: 8959924
Podlutsky A, Valcarcel-Ares MN, Yancey K, Podlutskaya V, Nagykaldi E, Gautam T, Miller RA, Sonntag WE, Csiszar A, Ungvari Z. The GH/IGF-1 axis in a critical period early in life determines cellular DNA repair capacity by altering transcriptional regulation of DNA repair-related genes: implications for the developmental origins of cancer. Geroscience. 2017;39:147–60. https://doi.org/10.1007/s11357-017-9966-x .
doi: 10.1007/s11357-017-9966-x pubmed: 28233247 pmcid: 5411369
Sonntag WE, Deak F, Ashpole N, Toth P, Csiszar A, Freeman W, Ungvari Z. Insulin-like growth factor-1 in CNS and cerebrovascular aging. Front Aging Neurosci. 2013;5:27. https://doi.org/10.3389/fnagi.2013.00027 .
doi: 10.3389/fnagi.2013.00027 pubmed: 23847531 pmcid: 3698444
Tarantini S, Balasubramanian P, Yabluchanskiy A, Ashpole NM, Logan S, Kiss T, Ungvari A, Nyul-Toth A, Schwartzman ML, Benyo Z, et al. IGF1R signaling regulates astrocyte-mediated neurovascular coupling in mice: implications for brain aging. Geroscience. 2021;43:901–11. https://doi.org/10.1007/s11357-021-00350-0 .
doi: 10.1007/s11357-021-00350-0 pubmed: 33674953 pmcid: 8110646
Tarantini S, Nyul-Toth A, Yabluchanskiy A, Csipo T, Mukli P, Balasubramanian P, Ungvari A, Toth P, Benyo Z, Sonntag WE, et al. Endothelial deficiency of insulin-like growth factor-1 receptor (IGF1R) impairs neurovascular coupling responses in mice, mimicking aspects of the brain aging phenotype. Geroscience. 2021;43:2387–94. https://doi.org/10.1007/s11357-021-00405-2 .
doi: 10.1007/s11357-021-00405-2 pubmed: 34383203 pmcid: 8599783
Tarantini S, Tucsek Z, Valcarcel-Ares MN, Toth P, Gautam T, Giles CB, Ballabh P, Wei JY, Wren JD, Ashpole NM, et al. Circulating IGF-1 deficiency exacerbates hypertension-induced microvascular rarefaction in the mouse hippocampus and retrosplenial cortex: implications for cerebromicrovascular and brain aging. Age (Dordr). 2016;38:273–89. https://doi.org/10.1007/s11357-016-9931-0 .
doi: 10.1007/s11357-016-9931-0 pubmed: 27613724
Tarantini S, Valcarcel-Ares NM, Yabluchanskiy A, Springo Z, Fulop GA, Ashpole N, Gautam T, Giles CB, Wren JD, Sonntag WE, et al. Insulin-like growth factor 1 deficiency exacerbates hypertension-induced cerebral microhemorrhages in mice, mimicking the aging phenotype. Aging Cell. 2017;16:469–79. https://doi.org/10.1111/acel.12583 .
doi: 10.1111/acel.12583 pubmed: 28295976 pmcid: 5418199
Toth L, Czigler A, Hegedus E, Komaromy H, Amrein K, Czeiter E, Yabluchanskiy A, Koller A, Orsi G, Perlaki G, et al. Age-related decline in circulating IGF-1 associates with impaired neurovascular coupling responses in older adults. Geroscience. 2022;44:2771–83. https://doi.org/10.1007/s11357-022-00623-2 .
doi: 10.1007/s11357-022-00623-2 pubmed: 35869380 pmcid: 9768079
Toth P, Tarantini S, Ashpole NM, Tucsek Z, Milne GL, Valcarcel-Ares NM, Menyhart A, Farkas E, Sonntag WE, Csiszar A, Ungvari Z. IGF-1 deficiency impairs neurovascular coupling in mice: implications for cerebromicrovascular aging. Aging Cell. 2015;14:1034–44. https://doi.org/10.1111/acel.12372 .
doi: 10.1111/acel.12372 pubmed: 26172407 pmcid: 4693458
Toth P, Tucsek Z, Tarantini S, Sosnowska D, Gautam T, Mitschelen M, Koller A, Sonntag WE, Csiszar A, Ungvari Z. IGF-1 deficiency impairs cerebral myogenic autoregulation in hypertensive mice. J Cereb Blood Flow Metab. 2014;34:1887–97. https://doi.org/10.1038/jcbfm.2014.156 .
doi: 10.1038/jcbfm.2014.156 pubmed: 25248835 pmcid: 4269740
Ungvari Z, Csiszar A. The emerging role of IGF-1 deficiency in cardiovascular aging: recent advances. J Gerontol A Biol Sci Med Sci. 2012;67:599–610. https://doi.org/10.1093/gerona/gls072 .
doi: 10.1093/gerona/gls072 pubmed: 22451468
Toth P, Csiszar A, Tucsek Z, Sosnowska D, Gautam T, Koller A, Schwartzman ML, Sonntag WE, Ungvari Z. Role of 20-HETE, TRPC channels, and BKCa in dysregulation of pressure-induced Ca2+ signaling and myogenic constriction of cerebral arteries in aged hypertensive mice. Am J Physiol Heart Circ Physiol. 2013;305:H1698-1708. https://doi.org/10.1152/ajpheart.00377.2013 .
doi: 10.1152/ajpheart.00377.2013 pubmed: 24097425 pmcid: 3882550
Toth P, Tarantini S, Springo Z, Tucsek Z, Gautam T, Giles CB, Wren JD, Koller A, Sonntag WE, Csiszar A, Ungvari Z. Aging exacerbates hypertension-induced cerebral microhemorrhages in mice: role of resveratrol treatment in vasoprotection. Aging Cell. 2015;14:400–8. https://doi.org/10.1111/acel.12315 .
doi: 10.1111/acel.12315 pubmed: 25677910 pmcid: 4406669
Toth P, Tucsek Z, Sosnowska D, Gautam T, Mitschelen M, Tarantini S, Deak F, Koller A, Sonntag WE, Csiszar A, Ungvari Z. Age-related autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension. J Cereb Blood Flow Metab. 2013;33:1732–42. https://doi.org/10.1038/jcbfm.2013.143 .
doi: 10.1038/jcbfm.2013.143 pubmed: 23942363 pmcid: 3824186
Ungvari Z, Wolin MS, Csiszar A. Mechanosensitive production of reactive oxygen species in endothelial and smooth muscle cells: role in microvascular remodeling? Antioxid Redox Signal. 2006;8:1121–9.
doi: 10.1089/ars.2006.8.1121 pubmed: 16910760
Csiszar A, Tucsek Z, Toth P, Sosnowska D, Gautam T, Koller A, Deak F, Sonntag WE, Ungvari Z. Synergistic effects of hypertension and aging on cognitive function and hippocampal expression of genes involved in beta-amyloid generation and Alzheimer’s disease. Am J Physiol Heart Circ Physiol. 2013;305:H1120-1130. https://doi.org/10.1152/ajpheart.00288.2013 .
doi: 10.1152/ajpheart.00288.2013 pubmed: 23955715 pmcid: 3798788
Tucsek Z, Noa Valcarcel-Ares M, Tarantini S, Yabluchanskiy A, Fulop G, Gautam T, Orock A, Csiszar A, Deak F, Ungvari Z. Hypertension-induced synapse loss and impairment in synaptic plasticity in the mouse hippocampus mimics the aging phenotype: implications for the pathogenesis of vascular cognitive impairment. Geroscience. 2017. https://doi.org/10.1007/s11357-017-9981-y .
doi: 10.1007/s11357-017-9981-y pubmed: 28664509 pmcid: 5636782
Massett MP, Ungvari Z, Csiszar A, Kaley G, Koller A. Different roles of PKC and MAP kinases in arteriolar constrictions to pressure and agonists. Am J Physiol Heart Circ Physiol. 2002;283:H2282–7.
doi: 10.1152/ajpheart.00544.2002 pubmed: 12427592
Springo Z, Toth P, Tarantini S, Ashpole NM, Tucsek Z, Sonntag WE, Csiszar A, Koller A, Ungvari ZI. Aging impairs myogenic adaptation to pulsatile pressure in mouse cerebral arteries. J Cereb Blood Flow Metab. 2015;35:527–30. https://doi.org/10.1038/jcbfm.2014.256 .
doi: 10.1038/jcbfm.2014.256 pubmed: 25605292 pmcid: 4420893
Szarka N, Pabbidi MR, Amrein K, Czeiter E, Berta G, Pohoczky K, Helyes Z, Ungvari Z, Koller A, Buki A, Toth P. Traumatic brain injury impairs myogenic constriction of cerebral arteries: role of mitochondria-derived H2O2 and TRPV4-dependent activation of BKca channels. J Neurotrauma. 2018. https://doi.org/10.1089/neu.2017.5056 .
doi: 10.1089/neu.2017.5056 pubmed: 29179622 pmcid: 5865628
Toth P, Szarka N, Farkas E, Ezer E, Czeiter E, Amrein K, Ungvari Z, Hartings JA, Buki A, Koller A. Traumatic brain injury-induced autoregulatory dysfunction and spreading depression-related neurovascular uncoupling: pathomechanisms, perspectives, and therapeutic implications. Am J Physiol Heart Circ Physiol. 2016;311:H1118–31. https://doi.org/10.1152/ajpheart.00267.2016 .
doi: 10.1152/ajpheart.00267.2016 pubmed: 27614225 pmcid: 5504422
Ungvari Z, Koller A. Endothelin and PGH
doi: 10.1161/01.HYP.36.5.856 pubmed: 11082156
Springo Z, Tarantini S, Toth P, Tucsek Z, Koller A, Sonntag WE, Csiszar A, Ungvari Z. Aging exacerbates pressure-induced mitochondrial oxidative stress in mouse cerebral arteries. J Gerontol A Biol Sci Med Sci. 2015;70:1355–9. https://doi.org/10.1093/gerona/glu244 .
doi: 10.1093/gerona/glu244 pubmed: 25631392 pmcid: 4612385
Weinert S, Poitz DM, Auffermann-Gretzinger S, Eger L, Herold J, Medunjanin S, Schmeisser A, Strasser RH, Braun-Dullaeus RC. The lysosomal transfer of LDL/cholesterol from macrophages into vascular smooth muscle cells induces their phenotypic alteration. Cardiovasc Res. 2013;97:544–52. https://doi.org/10.1093/cvr/cvs367 .
doi: 10.1093/cvr/cvs367 pubmed: 23250921
Yap C, Mieremet A, de Vries CJM, Micha D, de Waard V. Six shades of vascular smooth muscle cells illuminated by KLF4 (Kruppel-Like Factor 4). Arterioscler Thromb Vasc Biol. 2021;41:2693–707. https://doi.org/10.1161/ATVBAHA.121.316600 .
doi: 10.1161/ATVBAHA.121.316600 pubmed: 34470477 pmcid: 8545254
Zhang F, Guo X, Xia Y, Mao L. An update on the phenotypic switching of vascular smooth muscle cells in the pathogenesis of atherosclerosis. Cell Mol Life Sci. 2021;79:6. https://doi.org/10.1007/s00018-021-04079-z .
doi: 10.1007/s00018-021-04079-z pubmed: 34936041 pmcid: 11072026
Poittevin M, Lozeron P, Hilal R, Levy BI, Merkulova-Rainon T, Kubis N. Smooth muscle cell phenotypic switching in stroke. Transl Stroke Res. 2014;5:377–84. https://doi.org/10.1007/s12975-013-0306-x .
doi: 10.1007/s12975-013-0306-x pubmed: 24323725
Chen ZL, Yao Y, Norris EH, Kruyer A, Jno-Charles O, Akhmerov A, Strickland S. Ablation of astrocytic laminin impairs vascular smooth muscle cell function and leads to hemorrhagic stroke. J Cell Biol. 2013;202:381–95. https://doi.org/10.1083/jcb.201212032 .
doi: 10.1083/jcb.201212032 pubmed: 23857767 pmcid: 3718965
Wu J, Zhang Y, Yang P, Enkhjargal B, Manaenko A, Tang J, Pearce WJ, Hartman R, Obenaus A, Chen G, Zhang JH. Recombinant osteopontin stabilizes smooth muscle cell phenotype via integrin receptor/integrin-linked kinase/Rac-1 pathway after subarachnoid hemorrhage in rats. Stroke. 2016;47:1319–27. https://doi.org/10.1161/STROKEAHA.115.011552 .
doi: 10.1161/STROKEAHA.115.011552 pubmed: 27006454 pmcid: 4846549
Vengrenyuk Y, Nishi H, Long X, Ouimet M, Savji N, Martinez FO, Cassella CP, Moore KJ, Ramsey SA, Miano JM, Fisher EA. Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype. Arterioscler Thromb Vasc Biol. 2015;35:535–46. https://doi.org/10.1161/ATVBAHA.114.304029 .
doi: 10.1161/ATVBAHA.114.304029 pubmed: 25573853 pmcid: 4344402
Bickel MA, Sherry DM, Bullen EC, Vance ML, Jones KL, Howard EW, Conley SM. Microvascular smooth muscle cells exhibit divergent phenotypic switching responses to platelet-derived growth factor and insulin-like growth factor 1. Microvasc Res. 2024;151: 104609. https://doi.org/10.1016/j.mvr.2023.104609 .
doi: 10.1016/j.mvr.2023.104609 pubmed: 37716411
Tarantini S, Tran CHT, Gordon GR, Ungvari Z, Csiszar A. Impaired neurovascular coupling in aging and Alzheimer’s disease: contribution of astrocyte dysfunction and endothelial impairment to cognitive decline. Exp Gerontol. 2017;94:52–8. https://doi.org/10.1016/j.exger.2016.11.004 .
doi: 10.1016/j.exger.2016.11.004 pubmed: 27845201
Zhang Y, Yuan M, Bradley KM, Dong F, Anversa P, Ren J. Insulin-like growth factor 1 alleviates high-fat diet-induced myocardial contractile dysfunction: role of insulin signaling and mitochondrial function. Hypertension. 2012;59:680–93. https://doi.org/10.1161/HYPERTENSIONAHA.111.181867 .
doi: 10.1161/HYPERTENSIONAHA.111.181867 pubmed: 22275536
Stone RC, Kim S, Barnes BJ, Aviv A. Diverging antioxidative responses to IGF-1 in cultured human skin fibroblasts versus vascular endothelial cells. J Gerontol A Biol Sci Med Sci. 2012;67:939–46. https://doi.org/10.1093/gerona/gls081 .
doi: 10.1093/gerona/gls081 pubmed: 22466317 pmcid: 3536545
Hao CN, Geng YJ, Li F, Yang T, Su DF, Duan JL, Li Y. Insulin-like growth factor-1 receptor activation prevents hydrogen peroxide-induced oxidative stress, mitochondrial dysfunction and apoptosis. Apoptosis. 2011;16:1118–27. https://doi.org/10.1007/s10495-011-0634-9 .
doi: 10.1007/s10495-011-0634-9 pubmed: 21785846
Shai SY, Sukhanov S, Higashi Y, Vaughn C, Kelly J, Delafontaine P. Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability. Arterioscler Thromb Vasc Biol. 2010;30:1916–24. https://doi.org/10.1161/ATVBAHA.110.210831 .
doi: 10.1161/ATVBAHA.110.210831 pubmed: 20671230 pmcid: 2940990
Higashi Y, Sukhanov S, Anwar A, Shai SY, Delafontaine P. IGF-1, oxidative stress and atheroprotection. Trends Endocrinol Metab. 2010;21:245–54. https://doi.org/10.1016/j.tem.2009.12.005 .
doi: 10.1016/j.tem.2009.12.005 pubmed: 20071192 pmcid: 2848911
Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2007;27:2684–90. https://doi.org/10.1161/ATVBAHA.107.156257 .
doi: 10.1161/ATVBAHA.107.156257 pubmed: 17916769
Csiszar A, Labinskyy N, Perez V, Recchia FA, Podlutsky A, Mukhopadhyay P, Losonczy G, Pacher P, Austad SN, Bartke A, Ungvari Z. Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice. Am J Physiol Heart Circ Physiol. 2008;295:H1882-1894. https://doi.org/10.1152/ajpheart.412.2008 .
doi: 10.1152/ajpheart.412.2008 pubmed: 18757483 pmcid: 2614588
Obradovic M, Zafirovic S, Soskic S, Stanimirovic J, Trpkovic A, Jevremovic D, Isenovic ER. Effects of IGF-1 on the cardiovascular system. Curr Pharm Des. 2019;25:3715–25. https://doi.org/10.2174/1381612825666191106091507 .
doi: 10.2174/1381612825666191106091507 pubmed: 31692426
Ungvari Z, Yabluchanskiy A, Tarantini S, Toth P, Kirkpatrick AC, Csiszar A, Prodan CI. Repeated Valsalva maneuvers promote symptomatic manifestations of cerebral microhemorrhages: implications for the pathogenesis of vascular cognitive impairment in older adults. Geroscience. 2018;40:485–96. https://doi.org/10.1007/s11357-018-0044-9 .
doi: 10.1007/s11357-018-0044-9 pubmed: 30288646 pmcid: 6294721
de Alcantara BD, da Silva AE, Rosa JPP, Facundo LA, Costa CMA, Silva AC, Narciso FV, Silva A, de Mello MT. Can IGF-1 serum levels really be changed by acute physical exercise? A systematic review and meta-analysis. J Phys Act Health. 2020;17:575–84. https://doi.org/10.1123/jpah.2019-0453 .
doi: 10.1123/jpah.2019-0453
Norling AM, Gerstenecker AT, Buford TW, Khan B, Oparil S, Lazar RM. The role of exercise in the reversal of IGF-1 deficiencies in microvascular rarefaction and hypertension. Geroscience. 2020;42:141–58. https://doi.org/10.1007/s11357-019-00139-2 .
doi: 10.1007/s11357-019-00139-2 pubmed: 31808026
Qi C, Song X, Wang H, Yan Y, Liu B. The role of exercise-induced myokines in promoting angiogenesis. Front Physiol. 2022;13:981577. https://doi.org/10.3389/fphys.2022.981577 .
doi: 10.3389/fphys.2022.981577 pubmed: 36091401 pmcid: 9459110
Stein AM, da Silva TMV, Coelho FGM, Rueda AV, Camarini R, Galduroz RFS. Acute exercise increases circulating IGF-1 in Alzheimer’s disease patients, but not in older adults without dementia. Behav Brain Res. 2021;396:112903. https://doi.org/10.1016/j.bbr.2020.112903 .
doi: 10.1016/j.bbr.2020.112903 pubmed: 32937170
Stein AM, Silva TMV, Coelho FGM, Arantes FJ, Costa JLR, Teodoro E, Santos-Galduroz RF. Physical exercise, IGF-1 and cognition A systematic review of experimental studies in the elderly. Dement Neuropsychol. 2018;12:114–22. https://doi.org/10.1590/1980-57642018dn12-020003 .
doi: 10.1590/1980-57642018dn12-020003 pubmed: 29988330 pmcid: 6022990
Zebrowska A, Sikora M, Konarska A, Zwierzchowska A, Kaminski T, Robins A, Hall B. Moderate intensity exercise in hypoxia increases IGF-1 bioavailability and serum irisin in individuals with type 1 diabetes. Ther Adv Endocrinol Metab. 2020;11:2042018820925326. https://doi.org/10.1177/2042018820925326 .
doi: 10.1177/2042018820925326 pubmed: 32523674 pmcid: 7257872
Kord-Varkaneh H, Rinaldi G, Hekmatdoost A, Fatahi S, Tan SC, Shadnoush M, Khani V, Mousavi SM, Zarezadeh M, Salamat S, et al. The influence of vitamin D supplementation on IGF-1 levels in humans: a systematic review and meta-analysis. Ageing Res Rev. 2020;57:100996. https://doi.org/10.1016/j.arr.2019.100996 .
doi: 10.1016/j.arr.2019.100996 pubmed: 31816443
Hass U, Kochlik B, Herpich C, Rudloff S, Norman K. Effects of an omega-3 supplemented, high-protein diet in combination with vibration and resistance exercise on muscle power and inflammation in old adults: a pilot randomized controlled trial. Nutrients. 2022;14(20):4274. https://doi.org/10.3390/nu14204274 .
doi: 10.3390/nu14204274 pubmed: 36296958 pmcid: 9609960
Faakye J, Nyul-Toth A, Muranyi M, Gulej R, Csik B, Shanmugarama S, Tarantini S, Negri S, Prodan C, Mukli P, et al. Preventing spontaneous cerebral microhemorrhages in aging mice: a novel approach targeting cellular senescence with ABT263/navitoclax. Geroscience. 2023. https://doi.org/10.1007/s11357-023-01024-9 .
doi: 10.1007/s11357-023-01024-9 pubmed: 38123890 pmcid: 10828280
Zhang WB, Ye K, Barzilai N, Milman S. The antagonistic pleiotropy of insulin-like growth factor 1. Aging Cell. 2021;20:e13443. https://doi.org/10.1111/acel.13443 .
doi: 10.1111/acel.13443 pubmed: 34363732 pmcid: 8441393
Xie Y, Huang C, Zhu X, Wang J, Fan X, Fu Z, Ma Y, Hang D. Association between circulating insulin-like growth factor 1 and risk of all-cause and cause-specific mortality. Eur J Endocrinol. 2021;185:681–9. https://doi.org/10.1530/EJE-21-0573 .
doi: 10.1530/EJE-21-0573 pubmed: 34478404
Zhang WB, Aleksic S, Gao T, Weiss EF, Demetriou E, Verghese J, Holtzer R, Barzilai N, Milman S. Insulin-like growth factor-1 and IGF binding proteins predict all-cause mortality and morbidity in older adults. Cells. 2020;9(6):1368. https://doi.org/10.3390/cells9061368 .
doi: 10.3390/cells9061368 pubmed: 32492897 pmcid: 7349399
Barile L, Lionetti V, Cervio E, Matteucci M, Gherghiceanu M, Popescu LM, Torre T, Siclari F, Moccetti T, Vassalli G. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc Res. 2014;103:530–41. https://doi.org/10.1093/cvr/cvu167 .
doi: 10.1093/cvr/cvu167 pubmed: 25016614
Carrozzo A, Casieri V, Di Silvestre D, Brambilla F, De Nitto E, Sardaro N, Papini G, Storti S, Settanni G, Solinas M, et al. Plasma exosomes characterization reveals a perioperative protein signature in older patients undergoing different types of on-pump cardiac surgery. Geroscience. 2020. https://doi.org/10.1007/s11357-020-00223-y .
doi: 10.1007/s11357-020-00223-y pubmed: 32691393 pmcid: 8110632
Toth L, Czigler A, Horvath P, Kornyei B, Szarka N, Schwarcz A, Ungvari Z, Buki A, Toth P. Traumatic brain injury-induced cerebral microbleeds in the elderly. Geroscience. 2021;43:125–36. https://doi.org/10.1007/s11357-020-00280-3 .
doi: 10.1007/s11357-020-00280-3 pubmed: 33011936
Toth L, Czigler A, Horvath P, Szarka N, Kornyei B, Toth A, Schwarcz A, Ungvari Z, Buki A, Toth P. The effect of mild traumatic brain injury on cerebral microbleeds in aging. Front Aging Neurosci. 2021;13:717391. https://doi.org/10.3389/fnagi.2021.717391 .
doi: 10.3389/fnagi.2021.717391 pubmed: 34658836 pmcid: 8514735
Wilkinson CW, Pagulayan KF, Petrie EC, Mayer CL, Colasurdo EA, Shofer JB, Hart KL, Hoff D, Tarabochia MA, Peskind ER. High prevalence of chronic pituitary and target-organ hormone abnormalities after blast-related mild traumatic brain injury. Front Neurol. 2012;3:11. https://doi.org/10.3389/fneur.2012.00011 .
doi: 10.3389/fneur.2012.00011 pubmed: 22347210 pmcid: 3273706
Lithgow K, Chin A, Debert CT, Kline GA. Utility of serum IGF-1 for diagnosis of growth hormone deficiency following traumatic brain injury and sport-related concussion. BMC Endocr Disord. 2018;18:20. https://doi.org/10.1186/s12902-018-0247-1 .
doi: 10.1186/s12902-018-0247-1 pubmed: 29609574 pmcid: 5879553
Giuliano S, Talarico S, Bruno L, Nicoletti FB, Ceccotti C, Belfiore A. Growth hormone deficiency and hypopituitarism in adults after complicated mild traumatic brain injury. Endocrine. 2017;58:115–23. https://doi.org/10.1007/s12020-016-1183-3 .
doi: 10.1007/s12020-016-1183-3 pubmed: 27878771
Castellano AK, Powell JR, Cools MJ, Walton SR, Barnett RR, Delellis SM, Goldberg RL, Kane SF, Means GE, Zamora CA, et al. Relationship between anterior pituitary volume and IGF-1 serum levels in soldiers with mild traumatic brain injury history. Med Sci Sports Exerc. 2022;54:1364–70. https://doi.org/10.1249/MSS.0000000000002892 .
doi: 10.1249/MSS.0000000000002892 pubmed: 35838301 pmcid: 9287595
Bondanelli M, De Marinis L, Ambrosio MR, Monesi M, Valle D, Zatelli MC, Fusco A, Bianchi A, Farneti M, degli Uberti EC. Occurrence of pituitary dysfunction following traumatic brain injury. J Neurotrauma. 2004;21:685–96. https://doi.org/10.1089/0897715041269713 .
doi: 10.1089/0897715041269713 pubmed: 15253797
Nyul-Toth A, Tarantini S, Kiss T, Toth P, Galvan V, Tarantini A, Yabluchanskiy A, Csiszar A, Ungvari Z. Increases in hypertension-induced cerebral microhemorrhages exacerbate gait dysfunction in a mouse model of Alzheimer’s disease. Geroscience. 2020. https://doi.org/10.1007/s11357-020-00256-3 .
doi: 10.1007/s11357-020-00256-3 pubmed: 32844283 pmcid: 7732885

Auteurs

Levente Stankovics (L)

Department of Neurosurgery, Medical School, University of Pecs, Pecs, Hungary.

Anna Ungvari (A)

Institute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary. ungann2004@gmail.com.

Mónika Fekete (M)

Institute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.

Adam Nyul-Toth (A)

International Training Program in Geroscience, Doctoral College-Health Sciences Program/ Institute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Peter Mukli (P)

International Training Program in Geroscience, Doctoral College-Health Sciences Program/ Institute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Roland Patai (R)

Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Boglarka Csik (B)

International Training Program in Geroscience, Doctoral College-Health Sciences Program/ Institute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Rafal Gulej (R)

International Training Program in Geroscience, Doctoral College-Health Sciences Program/ Institute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Shannon Conley (S)

Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Anna Csiszar (A)

Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Peter Toth (P)

Department of Neurosurgery, Medical School, University of Pecs, Pecs, Hungary.
Institute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Classifications MeSH